Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3936

Movement disorder biotech Vima steps onto scene with $60M

$
0
0
Since Bernard Ravina's medical training in neurology in the 1990s, there have been few new therapies that treat a movement disorder known as dystonia. "Nothing fundamentally has changed for these patients since then," the drug ...

Viewing all articles
Browse latest Browse all 3936

Trending Articles